Evidence map›Paper›PMID 35633084›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2022

Prevalence of scars: an international epidemiological survey in adults.

J M Amici, C Taïeb, C LeFloc'h, A-L Demessant-Flavigny, S Seité, O Cogrel

Open access · hybridAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Scars.Nature reviews. Disease primers · 2023
    Review
  6. [Thinking and prospect of scar reconstruction].Zhonghua shao shang yu chuang mian xiu fu za zhi · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

J M AmiciDermatology Department, CHU Bordeaux, Hôpital Saint-André, Bordeaux, France.
C TaïebPatients Priority, European Market Maintenance Assessment, Fontenay-sous-Bois, France.ORCID 0000-0002-5142-2479
C LeFloc'hLa Roche-Posay, Levallois-Perret, France.
A-L Demessant-FlavignyLa Roche-Posay, Levallois-Perret, France.
S SeitéLa Roche-Posay, Levallois-Perret, France.
O CogrelDermatology Department, CHU Bordeaux, Hôpital Saint-André, Bordeaux, France.ORCID 0000-0002-8878-8351
Roche (France) · FRHôpital Saint-André · FREuropean Nuclear Safety Training & Tutoring Institute · FR

Funding

la Roche Posay
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CicatrixAdultHumansPrevalenceSurveys and Questionnaires

Identifiers

PMID35633084
PMCPMC9544440
OpenAlexW4281634377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.